On Sept. 30, 2026, the South China Morning Post reported that for the first time, China’s spending on…
On Sept. 29, 2026, China is offering the world’s brightest young scientists generous 15-year research grants for free…
On Sept. 21, 2026, the U.S. Department of Health and Human Services (HHS) announced a new wave of…
On Sept. 18, 2026, Eli Lilly and Company announced that the U.S. Food and Drug Administration(FDA) has granted…
On Sept. 17, 2026, investigators at Dana-Farber Cancer Institute and 23andMe Research Institute report that a rare inherited…
On Sept. 15, 2026, the U.S. Food and Drug Administration announced the final design of the Expedited Investigational…
On Sept. 8, 2026, Science funding cuts in the United States have led many researchers to seek out…
On Sept. 8, 2026, researchers from the University of California, Los Angeles (UCLA) announce they have developed a…
On Sept. 4, 2026, the U.S. Food and Drug Administration (FDA) announced they have expanded treatment options for…
On Aug. 28, 2026, scientists from Gladstone Institutes, UC San Francisco, and Stanford University, in collaboration with Biohub,…
On Aug. 26, 2026, the U.S. Food and Drug Administration (FDA) approved Rasonque (daraxonrasib), a RAS inhibitor for…
On Aug. 10, 2026, scientists at St. Jude Children’s Research Hospital announce they have created a single-cell atlas…
On Aug. 10, 2026, Labcorp announced that the U.S. Food and Drug Administration (FDA) had approved Labcorp’s PGDx elio®…
On Aug. 5, 2026, an international team led by researchers at MIT’s Koch Institute, the Broad Institute, the…
On Jul. 31, 2026, Novartis announced the US Food and Drug Administration (FDA) approved Pluvicto® (lutetium Lu 177…
On Jul. 30, 2026, a study led by Cedars-Sinai Health Sciences University investigators found that women who test…
On Jul. 30, 2026, researchers at the University of Virginia’s (UVA) Department of Radiology and Medical Imaging have…
On Jul. 30, 2026, researchers and clinicians from the University of Liverpool and the Clatterbridge Cancer Centre (CCC)…
On Jul. 28, 2026, The U.S. Food and Drug Administration (FDA) announced it had approved SimpleScreen™ CRC, a…
On Jul. 24, 2026, a team led by LIAN Jiazhang at Zhejiang University’s College of Chemical and Biological…
On Jul. 20, 2026, Tempus AI, a technology company leading the adoption of AI to advance precision medicine…
On Jul. 14, 2026, the Food and Drug Administration approved gedatolisib (Revtorpyk, Celcuity) in combination with fulvestrant, with…
On July 9, 2026, researchers at the University of British Columbia announced they have identified a new form of hereditary…
On Jul. 7, 2026, the Association of American Universities (AAU) released new data showing that major research universities…
On Jul. 3, 2026, a research team led by Helmholtz Munich and Ludwig Maximilian University has developed TAPIR,…
On Jul. 1, 2026, a study led by a researcher based at King’s College London and McMaster University…
On Jul. 1, 2026, tech giant Anthropic announced it has extended its foray into the life sciences space…
On Jun. 29, 2026, AstraZeneca and Daiichi Sankyo’s announced that Enhertu (trastuzumab deruxtecan) had been approved in the…
On Jun. 29, 2026, China announced it has broken ground on what developers say is the country’s first…
On Jun. 25, 2026, researchers from the Nara Institute of Science and Technology report that every time a…